{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:08:10Z","timestamp":1766754490287},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12928-017-0456-y","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T02:49:21Z","timestamp":1484966961000},"page":"116-124","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate"],"prefix":"10.1007","volume":"33","author":[{"given":"Masafumi","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishiro","family":"Chikamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Hijikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Yuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,21]]},"reference":[{"key":"456_CR1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","volume":"334","author":"NH Pijls","year":"1996","unstructured":"Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703\u20138.","journal-title":"N Engl J Med"},{"key":"456_CR2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne De","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991\u20131001.","journal-title":"N Engl J Med"},{"key":"456_CR3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jacc.2011.09.077","volume":"59","author":"NH Pijls","year":"2012","unstructured":"Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol. 2012;59:1045\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"456_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12928-016-0404-2","volume":"31","author":"H Matsuo","year":"2016","unstructured":"Matsuo H, Kawase Y. FFR and iFR guided percutaneous coronary intervention. Cardiovasc Interv Ther. 2016;31:183\u201395.","journal-title":"Cardiovasc Interv Ther"},{"key":"456_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1253\/circj.CJ-13-0161","volume":"77","author":"NH Pijls","year":"2013","unstructured":"Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561\u20139.","journal-title":"Circ J"},{"key":"456_CR6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCINTERVENTIONS.113.000591","volume":"6","author":"JM Tarkin","year":"2013","unstructured":"Tarkin JM, Nijjer S, Sen S, Petraco R, Echavarria-Pinto M, Asress KN, et al. Hemodynamic response to intravenous adenosine and its effect on fractional flow reserve assessment: results of the Adenosine for the Functional Evaluation of Coronary Stenosis Severity (AFFECTS) study. Circ Cardiovasc Interv. 2013;6:654\u201361.","journal-title":"Circ Cardiovasc Interv"},{"key":"456_CR7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/01.CIR.0000061950.24940.88","volume":"107","author":"B Bruyne De","year":"2003","unstructured":"De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, et al. Intracoronary and intravenous adenosine 5\u2032-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877\u201383.","journal-title":"Circulation"},{"key":"456_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2169\/internalmedicine.51.6567","volume":"51","author":"M Nakayama","year":"2012","unstructured":"Nakayama M, Saito A, Kitazawa H, Takahashi M, Sato M, Fuse K, et al. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases. Intern Med. 2012;51:351\u20136.","journal-title":"Intern Med"},{"key":"456_CR9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1253\/circj.CJ-14-1118","volume":"79","author":"M Nakayama","year":"2015","unstructured":"Nakayama M, Tanaka N, Sakoda K, Hokama Y, Hoshino K, Kimura Y, et al. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease. Circ J. 2015;79:530\u20136.","journal-title":"Circ J"},{"key":"456_CR10","doi-asserted-by":"crossref","first-page":"e000060","DOI":"10.1136\/openhrt-2014-000060","volume":"1","author":"V Mutha","year":"2014","unstructured":"Mutha V, Asrar Ul Haq M, Van Gaal WJ. Effects of intravenous caffeine on fractional flow reserve measurements in coronary artery disease. Open Heart. 2014;1:e000060.","journal-title":"Open Heart"},{"key":"456_CR11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ccd.21307","volume":"71","author":"RJ McGeoch","year":"2008","unstructured":"McGeoch RJ, Oldroyd KG. Pharmacological options for inducing maximal hyperaemia during studies of coronary physiology. Catheter Cardiovasc Interv. 2008;71:198\u2013204.","journal-title":"Catheter Cardiovasc Interv"},{"key":"456_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjcard.2003.10.017","volume":"93","author":"RA Aqel","year":"2004","unstructured":"Aqel RA, Zoghbi GJ, Trimm JR, Baldwin SA, Iskandrian AE. Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol. 2004;93:343\u20136.","journal-title":"Am J Cardiol"},{"key":"456_CR13","first-page":"580","volume":"26","author":"H Matsumoto","year":"2014","unstructured":"Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, et al. Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol. 2014;26:580\u20135.","journal-title":"J Invasive Cardiol"},{"key":"456_CR14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jcin.2015.01.039","volume":"8","author":"NP Johnson","year":"2015","unstructured":"Johnson NP, Johnson DT, Kirkeeide RL, Berry C, De Bruyne B, Fearon WF, et al. Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC Cardiovasc Interv. 2015;8:1018\u201327.","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 1","key":"456_CR15","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc12-s064","volume":"35","author":"Diabetes A American","year":"2012","unstructured":"American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64\u201371.","journal-title":"Diabetes Care"},{"key":"456_CR16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159\u2013219.","journal-title":"Eur Heart J"},{"key":"456_CR17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.5551\/jat.17368","volume":"20","author":"T Teramoto","year":"2013","unstructured":"Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version. J Atheroscler Thromb. 2013;20:733\u201342.","journal-title":"J Atheroscler Thromb"},{"key":"456_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1213\/00000539-198203000-00010","volume":"61","author":"AF Fukunaga","year":"1982","unstructured":"Fukunaga AF, Flacke WE, Bloor BC. Hypotensive effects of adenosine and adenosine triphosphate compared with sodium nitroprusside. Anesth Analg. 1982;61:273\u20138.","journal-title":"Anesth Analg"},{"key":"456_CR19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/01.CIR.101.3.318","volume":"101","author":"A Jeremias","year":"2000","unstructured":"Jeremias A, Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, et al. Effects of intravenous and intracoronary adenosine 5\u2032-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation. 2000;101:318\u201323.","journal-title":"Circulation"},{"key":"456_CR20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.CIR.82.5.1595","volume":"82","author":"RF Wilson","year":"1990","unstructured":"Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 1990;82:1595\u2013606.","journal-title":"Circulation"},{"key":"456_CR21","first-page":"123","volume":"30","author":"XM Zheng","year":"2002","unstructured":"Zheng XM, Williams RC. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging. J Nucl Med Technol. 2002;30:123\u20137.","journal-title":"J Nucl Med Technol"},{"key":"456_CR22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jacc.2008.08.052","volume":"52","author":"E Reyes","year":"2008","unstructured":"Reyes E, Loong CY, Harbinson M, Donovan J, Anagnostopoulos C, Underwood SR. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll Cardiol. 2008;52:2008\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"456_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0773.1995.tb00111.x","volume":"76","author":"BB Fredholm","year":"1995","unstructured":"Fredholm BB. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76:93\u2013101.","journal-title":"Pharmacol Toxicol"},{"key":"456_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0168-8278(92)90152-F","volume":"14","author":"FW Lewis","year":"1992","unstructured":"Lewis FW, Rector WG Jr. Caffeine clearance in cirrhosis: the value of simplified determinations of liver metabolic capacity. J Hepatol. 1992;14:157\u201362.","journal-title":"J Hepatol"},{"key":"456_CR25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.295.10.1135","volume":"295","author":"MC Cornelis","year":"2006","unstructured":"Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135\u201341.","journal-title":"JAMA"},{"key":"456_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/j.1552-4604.1997.tb04356.x","volume":"37","author":"GB Kaplan","year":"1997","unstructured":"Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, et al. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997;37:693\u2013703.","journal-title":"J Clin Pharmacol"},{"key":"456_CR27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00006231-200004000-00011","volume":"21","author":"J Majd-Ardekani","year":"2000","unstructured":"Majd-Ardekani J, Clowes P, Menash-Bonsu V, Nunan TO. Time for abstention from caffeine before an adenosine myocardial perfusion scan. Nucl Med Commun. 2000;21:361\u20134.","journal-title":"Nucl Med Commun"},{"key":"456_CR28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0735-1097(84)80233-8","volume":"4","author":"B Belhassen","year":"1984","unstructured":"Belhassen B, Pelleg A. Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: clinical and experimental aspects. J Am Coll Cardiol. 1984;4:414\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"456_CR29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCINTERVENTIONS.111.965392","volume":"5","author":"MK Seo","year":"2012","unstructured":"Seo MK, Koo BK, Kim JH, Shin DH, Yang HM, Park KW, et al. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement. Circ Cardiovasc Interv. 2012;5:401\u20135.","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-017-0456-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-017-0456-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-017-0456-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T16:54:18Z","timestamp":1522688058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-017-0456-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s12928-017-0456-y","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,21]]}}}